The highest estimate is 82.00. From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow GRAL V. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.
Depending on the exchange, the stock ticker may vary. For instance, on exchange GRAIL stocks are traded under the ticker GRAL V.
When is the next GRAIL earnings date?▼
GRAIL is going to release the next earnings report on May 19, 2026.
What were GRAIL earnings last quarter?▼
GRAL V earnings for the last quarter are -2.44 USD per share, whereas the estimation was -2.7 USD resulting in a +9.63% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is GRAIL revenue for the last year?▼
GRAIL revenue for the last year amounts to 103.58M USD.
What is GRAIL net income for the last year?▼
GRAL V net income for the last year is -309.18M USD.
How many employees does GRAIL have?▼
As of April 29, 2026, the company has 1,000 employees.
In which sector is GRAIL located?▼
GRAIL operates in the Health & Wellness sector.
When did GRAIL complete a stock split?▼
GRAIL has not had any recent stock splits.
Where is GRAIL headquartered?▼
GRAIL is headquartered in Menlo Park, United States.